Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

Restructuring Expenses and Financial Guidance Cash payments resulting from the restructuring are estimated to be $5.5 to $6.5 million ... Sponsored Clinical Trial of NKX019 for Generalized Myasthenia ...

It was performed to help diagnose myasthenia gravis (MG), a neuromuscular junction condition characterized ... Front Neurosci. 2016 Jun 6;10:226. doi10.3389/fnins.2016.00226. Dr. Moawad is a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The expanded application makes this the first ...

for pediatric patients aged six years and older with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. This landmark approval makes Soliris the ...

Myasthenia gravis patients show higher rates of dysarthria, dysphonia, dysphagia, and aspiration pneumonia compared to non-affected individuals. Despite high disorder rates, most myasthenia gravis ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular ...

The EuGMS Myasthenia Gravis Group has recently proposed a consensus protocol for muscle assessment using ultrasound, which involves the measurement of muscle thickness, cross-sectional area, fascicle ...

The nicotinic acetylcholine receptor (nAChR) is a major target of autoantibodies in myasthenia gravis (MG), an autoimmune disease that causes neuromuscular transmission dysfunction. Despite decades of ...